Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

Clinical trial NCT02292784 · COMPLETED

Trial details

NCT number: NCT02292784
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obstetric Labour, Premature

Start date: 2015-06-01
Primary completion: 2019-09-02
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.